C12Q 1/707
Non-a, non-b hepatitis, excluding hepatitis d
Official title: {non-A, non-B Hepatitis, excluding hepatitis D}
C12Q1/707 (Non-a, non-b hepatitis, excluding hepatitis d) appears on 281 US grants and 365 published applications in this corpus.
Search patents in C12Q- Granted patents
- 281
- Published applications
- 365
- Assignees
- 225
- Inventors
- 791
- Latest grant
- 6 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 2 | 0 |
| 1994 | 4 | 0 |
| 1995 | 3 | 0 |
| 1996 | 4 | 0 |
| 1997 | 5 | 0 |
| 1998 | 13 | 0 |
| 1999 | 12 | 0 |
| 2000 | 13 | 0 |
| 2001 | 18 | 1 |
| 2002 | 9 | 16 |
| 2003 | 10 | 26 |
| 2004 | 4 | 18 |
| 2005 | 10 | 19 |
| 2006 | 5 | 13 |
| 2007 | 11 | 18 |
| 2008 | 6 | 7 |
| 2009 | 6 | 17 |
| 2010 | 11 | 23 |
| 2011 | 9 | 14 |
| 2012 | 14 | 28 |
| 2013 | 8 | 17 |
| 2014 | 5 | 23 |
| 2015 | 6 | 17 |
| 2016 | 15 | 26 |
| 2017 | 6 | 23 |
| 2018 | 18 | 13 |
| 2019 | 20 | 9 |
| 2020 | 10 | 9 |
| 2021 | 7 | 5 |
| 2022 | 9 | 5 |
| 2023 | 1 | 11 |
| 2024 | 2 | 2 |
| 2025 | 3 | 1 |
| 2026 | 1 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Exosome-mediated diagnosis of hepatitis virus infections and diseases6 Jan 2026US 12,517,129 B2Morehouse School of Medicine
- Method for evaluation of viability of viruses with lymphotropism properties18 Nov 2025US 12,473,603 B2
- Methods and compositions for detecting transfusion-transmitted pathogens12 Aug 2025US 12,385,104 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Fragmentation for measuring methylation and disease25 Mar 2025US 12,258,634 B2Centre for Novostics
- Reagents and methods for detecting HCV21 May 2024US 11,987,851 B2Siemens Healthcare Diagnostics Inc.
- High-yield genotype 1a, 2a and 3a hcv10 Sep 2026US 2026/0263580 A1Hvidovre Hospital
- Programmable rna detection using pseudo-guide dna using cas12i and cas12a20 Aug 2026US 2026/0242852 A1
- Hcv detection13 Aug 2026US 2026/0234739 A1Diagnostics for the Real World, Ltd.
- Molecular signatures to predict long-term liver fibrosis progression2 Jul 2026US 2026/0185169 A1Board of Regents, The University of Texas System
- Circular rna derived from rna viruses and related compositions and methods30 Jan 2025US 2025/0034573 A1CZ Biohub SF, LLC
Most cited
By later US patents
- Ribonuclease resistant viral RNA standards180US 5,677,124 AAmbion, Inc. · 1997
- HCV immunoassays employing C domain antigens147US 5,350,671 AChiron Corporation · 1994
- Gas inlet for a plurality of reactant gases into reaction vessel142US 5,441,703 AAixtron SE · 1995
- Methods, primers and probes for detection of hepatitis C and novel variants107US 5,527,669 AHoffmann-La Roche Inc. · 1996
- Compositions and methods for treatment of hepatitis C virus-associated diseases99US 6,174,868 B1Isis Pharmaceuticals, Inc. · 2001